Revance Therapeutics Inc (NASDAQ:RVNC) Short Interest Down 18.6% in September - OCTOBER 1 Report
Revance Therapeutics Inc (NASDAQ:RVNC) saw a significant drop in short interest in September. As of September 15th, there was short interest totalling 4,430,000 shares, a drop of 18.6% from the August 31st total of 5,440,000 shares. Based on an average daily volume of 589,800 shares, the days-to-cover ratio is currently 7.5 days.